Table III.
A, KRAS mutation status in toto | ||||
---|---|---|---|---|
Confidence interval | ||||
Parameter | Odds Ratio | Lower | Upper | P-value |
TTM | ||||
KRAS status | 1.187 | 0.816 | 1.726 | 0.198 |
Female and KRAS status | 0.799 | 0.444 | 1.439 | 0.254 |
Male and KRAS status | 1.583 | 0.962 | 2.606 | 0.035 |
OS | ||||
KRAS status | 1.286 | 0.874 | 1.903 | 0.107 |
Female and KRAS status | 1.151 | 0.825 | 2.766 | 0.100 |
Male and KRAS status | 1.141 | 0.679 | 1.935 | 0.345 |
B, KRAS codon-specific mutations | ||||
Confidence interval | ||||
Parameter | P-value | Hazard ratio | Lower | Upper |
TTM | ||||
Gender | 0.011 | 0.728 | 0.569 | 0.931 |
Age at diagnosis | 0.473 | 1.161 | 0.771 | 1.750 |
Codon 12 mutations | 0.907 | 1.037 | 0.559 | 1.924 |
Codon 13 mutations | 0.861 | 1.045 | 0.634 | 1.721 |
Other codon mutations | 0.806 | 1.076 | 0.598 | 1.935 |
TTM, time to first metastasis; OS, overall survival.